Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Trip 

AbbVie Inc. diskutieren

AbbVie Inc.

WKN: A1J84E / Symbol: ABBV / Name: AbbVie / Aktie / Pharmazeutika / Large Cap /

167,40 €
0,48 %

Buy AbbVie Inc.

Buy AbbVie Inc.

Einschätzung Buy
Rendite (%) 16,95 %
Kursziel
Veränderung
Endet am 21.10.19

Buy beendet

Sell AbbVie Inc.

Einschätzung Buy
Rendite (%) 18,05 %
Kursziel
Veränderung
Endet am 13.12.19

Buy beendet

Einschätzung Sell
Rendite (%) 0,25 %
Kursziel
Veränderung
Endet am 21.01.20

Sell beendet

Buy AbbVie Inc.

Sell AbbVie Inc.

Buy AbbVie Inc.

Buy AbbVie Inc.

Sell AbbVie Inc.

Buy AbbVie Inc.

Buy AbbVie Inc.

Sell AbbVie Inc.

Buy AbbVie Inc.

AbbVie Inc. (NYSE: ABBV) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Ratings data for ABBV provided by MarketBeat

AbbVie Inc. (NYSE: ABBV) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for ABBV provided by MarketBeat

AbbVie Inc. (NYSE: ABBV) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for ABBV provided by MarketBeat

Einschätzung Buy
Rendite (%) 23,80 %
Kursziel 154,21
Veränderung
Endet am 28.07.24

AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Piper Jaffray Companies from $163.00 to $170.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat

AbbVie Inc. (NYSE: ABBV) is now covered by analysts at Raymond James. They set an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat